A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis Read More
May 2, 2026
People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little evidence Read More
American innovator REalloys (NASDAQ: ALOY) is bringing rare earth metals, the backbone of the U.S. defense industry and the Read More
Increasing numbers of Australians are using medicinal cannabis for anxiety, depression, insomnia, substance disorders and more. Is it safe? And Read More
Lawmakers sent ten cannabis-related bills to the desk of Democratic Governor Abigail Spanberger for her review. The post Sweeping Changes Read More
Abstract Background Youth in sub-Saharan Africa are at high risk of substance use yet lack access to appropriate interventions. The Read More
VANCOUVER, British Columbia, March 16, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the Company or Cannabix) is Read More
New randomized controlled trial to evaluate dose-dependent effects of oral THC on anxiety and stress using Avicanna’s proprietary capsules Read More
While younger cannabis enthusiasts still outnumber older ones, adults 65 and up were the fastest-growing segment of users during most of Read More
REalloys (NASDAQ: ALOY) built something that barely exists anywhere in the Western world — a rare earth supply chain that doesn’Read More